Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav(®)) in Sleep Disorders: A Profile of Its Use

Calcium, magnesium, potassium and sodium oxybates (Xywav(®); hereafter referred to as lower-sodium oxybate), a new oxybate formulation with a greatly reduced sodium burden compared with previously approved sodium oxybate (Xyrem(®)), is approved for the treatment of cataplexy and excessive daytime sl...

Descripción completa

Detalles Bibliográficos
Autor principal: Heo, Young-A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Adis Drug Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095545/
https://www.ncbi.nlm.nih.gov/pubmed/35357671
http://dx.doi.org/10.1007/s40263-022-00912-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095545/
https://www.ncbi.nlm.nih.gov/pubmed/35357671
http://dx.doi.org/10.1007/s40263-022-00912-6

Ejemplares similares